Pelvic Floor Muscle Exercises and Core Exercises in Menopausal Women

What this trial studies

The prospective and four-arm randomized controlled study was conducted on n = 136 (34 = control, 34 = kegel, 34 = core, 34 = kegel+ core group) menopausal women at Trakya University Health Research and Application Center Urology Polyclinic between Oct 2023 and June 2024. In the first interview, the researcher will apply an information form to all four groups, asking about personal information, habits, bladder irritants and fluid intake-related features, obstetric, gynecological and systemic disease-related features, and stress urinary incontinence-related features. This form will only be filled at the beginning. In addition, the \"Pelvic Floor Distress Scale (PFDI)\" and \"Pelvic Floor Impact Questionnaire (PFIQ)\" will be applied and will be repeated by the executive researcher at the 1st, 2nd and 3rd controls.

Conditions in scope

• Menopause
• Stress Urinary Incontinence
• Kegel Exercises
• Core Strength

Interventions

• Pelvic Floor Muscle Exercise (Other) — Training for PFME will be given orally and will cover the importance of FME and how to do the exercises, as well as the conditions and frequency of doing the exercises. You will be told that the exercise should be…
• Core Exercise (Other) — Activating the contraction of the deep core muscles TrA and mutifidus without disrupting breathing forms the basis of core stabilization exercises. To teach the \"abdominal hallowing\" maneuver, which enables the activation of these muscles, patients will be shown a picture…

Who can join

Women only · Ages 45 Years and up

Inclusion criteria

• Volunteer to participate in the study,
• Those over the age of 45 who are in menopause,
• Women with coitus (+),
• Body mass index \< 30 kg/m2,
• Not addicted to alcohol or drugs,
• Experiences recorded unintentional leakage more than once a week,
• Those diagnosed with Stage I-II stress urinary incontinence complaints, Patients whose stress incontinence does not require surgical or medical treatment will be included in the study.

Exclusion criteria

• Those who do not volunteer to participate in the study,
• Women who are under the age of 45 and are not in menopause,
• Women with (-) coitus,
• Having a pacemaker installed,
• Presence of a device implanted in the pelvis or hip joint(s),
• Having had pelvic or abdominal surgery in the last 6 months,
• Having a neurological or psychiatric disease,
• Having a urinary tract infection,

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

Status & timeline

• Overall status: Completed
• Study type: Interventional
• Phase: N/A
• Start date: 2023-10-15
• Primary completion: 2024-04-20
• Last update posted: 2025-01-31
• First posted: 2024-04-04

Sponsor & contact

Lead sponsor: Trakya University (Other)

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

• Pelvic floor evaluated using the Pelvic Floor Distress Inventory (PFDI - Pelvic Floor Distress Inventionary) (change from baseline and 1, 2, and 3 months of practice)
  PFDI is a symptom questionnaire consisting of 20 items used to measure the degree of discomfort caused by pelvic symptoms in women. Each item consists of 4 options (Not at all, Rarely, Moderately, Quite a lot) and is given a score between 1 and 4. PFDI consists of 3 subscales.
• Pelvic floor impact evaluated using the Pelvic Floor Impact Questionnaire (PFIQ Pelvic Floor Impact Questionnaire) (change from baseline and 1, 2, and 3 months of practice)
  PFIQ is a pelvic floor quality of life questionnaire used to evaluate the effects of bowel, bladder and/or pelvic symptoms on the individual's daily living activities, social relationships and emotions. Each item consists of 4 options (Not at all, Rarely, Moderately, Quite a lot) and is given a score between 0 and 3. The PFIQ scale also consists of 3…

Related ClearedRx care

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.